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Abstract
Background: SCF ubiquitin ligases target numerous proteins for ubiquitin dependent proteolysis,
including p27 and cyclin E. SCF and other cullin-RING ligases (CRLs) are regulated by the ubiquitin-
like protein Nedd8 that covalently modifies the cullin subunit. The removal of Nedd8 is catalyzed
by the Jab1/MPN domain metalloenzyme (JAMM) motif within the Csn5 subunit of the Cop9
Signalosome.
Results: Here, we conditionally knock down Csn5 expression in HEK293 human cells using a
doxycycline-inducible shRNA system. Cullin levels were not altered in CSN-deficient human cells,
but the levels of multiple F-box proteins were decreased. Molecular analysis indicates that this
decrease was due to increased Cul1- and proteasome-dependent turnover. Diminished F-box
levels resulted in reduced SCF activity, as evidenced by accumulation of two substrates of the F-
box protein Fbw7, cyclin E and c-myc, in Csn5-depleted cells.
Conclusion: We propose that deneddylation of Cul1 is required to sustain optimal activity of SCF
ubiquitin ligases by repressing 'autoubiquitination' of F-box proteins within SCF complexes, thereby
rescuing them from premature degradation.
Background
Proteins are marked for degradation by the 26S proteas-
ome via the covalent attachment of chains of the 76-
amino acid protein ubiquitin [reviewed in [1]]. This proc-
ess involves three discreet steps. First, ubiquitin is acti-
vated by the ubiquitin conjugating enzyme (E1) through
the hydrolysis of ATP to AMP to yield a high energy
thioester intermediate between the C-terminal glycine of
ubiquitin and the catalytic cysteine of the E1.
Subsequently, ubiquitin is transferred onto the catalytic
cysteine of one of many ubiquitin conjugating enzymes
(E2) which, in turn, transfer their cargo onto substrates
with the help of ubiquitin ligase enzymes (E3).
One of the best-studied E3 ubiquitin ligase enzymes is the
four subunit complex SCF [reviewed in [2]]. SCF consists
of two activities: the first, contained within the Cul1 and
RING domain Hrt1/Roc1/Rbx1 proteins, is the ability to
recruit and activate the E2 to facilitate ubiquitin transfer
from the E2 onto substrate; the second resides within the
variable F-box proteins, which are linked to Cul1 via Skp1
and are thought to recruit substrates for ubiquitination by
the Cul1/Hrt1 sub-complex. The large number of different
F-box proteins gives SCF the opportunity to access a wide
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array of substrates. In yeast, over 19 F-box proteins are
known, in A. thaliana over 400, and in humans ~70 [2].
The family of SCF ligases in turn is the prototype for a
superfamily of cullin-RING ligases that, like SCF, are mod-
ular enzymes comprising a cullin-RING subcomplex
linked to a variable substrate receptor subunit (VHL box
proteins for Cul2, BTB proteins for Cul3, and SOCS box
proteins for Cul5). Altogether, the human genome may
have the capacity to code for as many as 350 different
CRLs.
Given the diversity of CRL substrate receptor proteins, two
important questions emerge. First, how is the repertoire of
CRLs dynamically controlled? Second, are distinct CRL
complexes differentially regulated in a manner that
depends on the identity of the substrate receptor? One
partial answer to both of these questions is that F-box and
other substrate receptors are often unstable proteins, and
it is thought that they are targeted for degradation in part
by 'autoubiquitination' within SCF-E2 complexes [2].
However, not all CRL substrate receptors are unstable, and
thus there must be some means of differentially control-
ling their stability. There are multiple ways in which this
might be accomplished. First, CRL ubiquitin ligase activity
is negatively regulated by Cop9 Signalosome (CSN) in
vitro [3-6]. CSN cleaves the ubiquitin-like protein Nedd8
from the cullin subunit of CRLs [3,7]. Attachment of
Nedd8 to Cul1 strongly stimulates the ability of the Cul1-
Hrt1/Roc1/Rbx1 catalytic core to promote ubiquitin chain
synthesis by Cdc34 E2 enzyme [8-10]. Once Nedd8 is
detached, CAND1 can bind Cul1 and displace Skp1,
thereby preventing the recruitment of substrate to the cat-
alytic core [11,12]. In addition to removing Nedd8, CSN
also recruits a deubiquitinating enzyme to Cul1, Ubp12,
that opposes ubiquitin polymerization [6,13]. Thus, CSN
may play a key role in controlling the dynamics of indi-
vidual CRL complexes and the overall repertoire of differ-
ent CRL complexes in a cell.
CSN is a highly conserved protein complex found from
yeast to humans. CSN is composed of eight subunits,
termed Csn1-Csn8 [14] and each of these subunits con-
tains high homology to components of the 26S proteas-
ome lid subcomplex and eukaryotic Initiation Factor 3
(eIF3) [reviewed in [15]]. CSN has been found to play
diverse roles in several different organisms [reviewed in
[15]]. In A. thaliana, CSN components were identified in
a screen for plants that displayed a constitutive photomor-
phogenic defect (plants develop in the dark as they would
in the light). In D. melanogaster, mutations in Csn4 and
Csn5 result in pleitropic effects, including activation of
meiotic checkpoints [16,17] and failure of photoreceptor
neurons to differentiate [18]. RNAi of Csn5 in C. elegans
additionally results in pleitropic effects, including sterile
worms and alterations in microtubules [19].
Although the molecular basis behind many of these phe-
notypes has yet to be elucidated, it is becoming evident
that deneddylation of cullins catalyzed by the 'JAMM'
metalloprotease active site motif in the Csn5 subunit is at
least partially responsible. Transgenic csn5 with mutations
in the JAMM motif fails to correct the developmental
defects of csn5-delete flies [20]. Moreover, failure to
deneddylate Cul3 in C. elegans is implicated in accumula-
tion of the microtubule severing protein Mei-1, which
results in microtubule defects [19,21].
The effects of loss of deneddylation of cullin proteins are
still not understood. Loss of CSN function causes a defect
in cullin-based ligase activity in vivo suggesting that
deneddylation promotes SCF activity [4,7,20-25]. How-
ever, in vitro data suggests a negative role for CSN in regu-
lation of SCF [3-6]. What may account for this
discrepancy? One hypothesis suggests that neddylation
and deneddylation affect cycles of assembly of CRL com-
plexes and the stability of substrate adaptor proteins in
vivo [15,6].
In an effort to investigate how loss of deneddylation
affects SCF activity, we conditionally silenced the catalytic
subunit of CSN in mammalian cells. Suppression of Csn5
protein resulted in a significant decrease in the F-box pro-
teins Skp2, cyclin F, Fbx7, Fbx4, and Fbw7. Moreover,
mRNA transcripts for all but one of these F-box proteins
were unaltered when CSN5 was suppressed, suggesting
the decreases in protein levels are post-translational. Con-
sistent with this notion, treatment with proteasome inhib-
itors largely restored the levels of multiple F-box proteins
and dominant-negative Cul1 prevented loss of cyclin F.
Finally, we found a dramatic increase in the protein and
activity levels of the SCFFbw7 substrate cyclin E, suggesting
that loss of F-box proteins in CSN-deficient cells results in
substrate accumulation.
Results
Depletion of CSN5 in HEK293 cells is not lethal
To analyze the effect of loss of deneddylation in human
cells, we utilized the doxycyline-inducible shRNA system
developed by Clevers and colleagues [26] to conditionally
down-regulate Csn5 protein levels. Eight days of doxycy-
cline treatment of cells carrying the inducible Csn5-spe-
cific shRNA resulted in a drastic reduction in both Csn5
mRNA and protein levels when compared to induced cells
expressing a scrambled shRNA (Figures 1A and 1B). By
contrast, the levels of other CSN subunits showed little or
no change (Figure 1C). Despite this significant drop in
Csn5 protein levels, few morphological changes were
observed, the cells continued to grow and divide, and lit-
tle change in steady-state cell cycle distribution was
detected by FACS (data not shown). This is consistent
with prior observations on normal diploid BJ1 fibroblastsBMC Biochemistry 2006, 7:1 http://www.biomedcentral.com/1471-2091/7/1
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Suppression of Csn5 in HEK 293 human cells Figure 1
Suppression of Csn5 in HEK 293 human cells. (A) Expression of Csn5-specific shRNA suppresses endogenous Csn5 
mRNA levels. Cells induced with doxycycline for 8 days were harvested and analyzed by RT-PCR using oligos specific for Csn5. 
(B) Expression of Csn5-specific shRNA suppresses endogenous Csn5 protein levels. Cells induced with doxycycline for 8 days 
were harvested and lysed. Lysates were analyzed by western blot using antibodies specific toward human Csn5. (C) Silencing 
of Csn5 does not appreciably affect the levels of other CSN subunits. Cells induced with doxycycline for 8 days were har-
vested, and cell lysates were analyzed by western with the antibodies indicated. (D) Silencing of Csn5 results in altered cullin 
neddylation. Cells were induced with doxycycline for 8 days and harvested. Cells were lysed and analyzed by western blot 
using the antibodies indicated.BMC Biochemistry 2006, 7:1 http://www.biomedcentral.com/1471-2091/7/1
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depleted of Csn5 [4]. Given that loss of CSN function
results in accumulation of the neddylated form of cullins
in yeast, Drosophila, and C. elegans, we analyzed the
endogenous cullins 1–4 by western blot in human cells
depleted of Csn5. Loss of Csn5 resulted in enhanced ned-
dylation of all four cullins, although to varying extents
(Figure 1D). The failure to observe complete conversion
of all cullins to the neddylated species – as was seen for
Cul1 in csn1∆ S. pombe cells [3] – may be due to residual
Csn5 activity, an alternative cullin deneddylase, limiting
Nedd8 attachment activity, or the sequestration of dened-
dylated cullins into complexes with CAND1 [12]. Despite
the change in Nedd8 modification, the total levels of cul-
lins 1–4 were largely unaltered in Csn5-depeleted human
cells, except for a modest reduction in the level of Cul2.
Loss of deneddylation causes a reduction in F-box protein 
levels
It has been proposed that loss of deneddylation could
render F-box adaptor proteins unstable [6,15]. To test this
hypothesis, we analyzed the levels of several endogenous
F-box proteins in cells depleted of Csn5. In this experi-
ment and throughout this report, we focused our effort on
endogenous proteins to avoid potential artifacts associ-
ated with overexpression of recombinant proteins. Con-
comitant with loss of Csn5, we observed significant
Loss of Csn5 results in a decrease in F-box protein levels Figure 2
Loss of Csn5 results in a decrease in F-box protein levels. (A) Depletion of Csn5 results in a decrease in F-box protein 
levels. Cells were treated with doxycycline for eight days followed by lysis and SDS-PAGE/western blot analysis with antibodies 
toward the proteins indicated. (B) Depletion of Csn5 does not affect F-box protein mRNA levels. Cells were treated with 
doxycycline for eight days and analyzed by RT-PCT using oligos specific toward the mRNAs indicated.BMC Biochemistry 2006, 7:1 http://www.biomedcentral.com/1471-2091/7/1
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Loss of Csn5 results in proteasome-dependent turnover of F-box proteins Figure 3
Loss of Csn5 results in proteasome-dependent turnover of F-box proteins. (A) Supplementation of doxycycline-
treated cells with MG132 inhibits the turnover of F-box proteins. Cells were treated with doxycycline for eight days followed 
by treatment with MG132 (25 µM) for eight hours. Cells were lysed in SDS and analyzed by SDS-PAGE/western blot for the 
indicated proteins. (B) Ectopic expression of wild-type, but not JAMM point mutant Csn5, can rescue the decrease in protein 
levels of Skp2 and cyclin F. Cells were treated with doxycycline for six days, followed by transient transfection with wild-type 
Flag-Csn5, Flag-Csn5 (ASA), or Flag-Csn5 (D151N). Forty-eight hours post-transfection, cells were lysed in SDS and analyzed 
by SDS-PAGE/western blot for the indicated proteins. (C) Ectopic expression of a dominant-negative Cul1 restores cyclin F 
protein levels. Control, wild-type, or Cul1 (1–428) expression plasmids were transfected into cells induced with doxycycline 
for six days. Forty-eight hours post-transfection, cells were lysed in SDS and analyzed by SDS-PAGE/western blot with antibod-
ies against the indicated proteins.BMC Biochemistry 2006, 7:1 http://www.biomedcentral.com/1471-2091/7/1
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Loss of Csn5 results in an increase in cyclin E, an F-box protein substrate Figure 4
Loss of Csn5 results in an increase in cyclin E, an F-box protein substrate. (A) Substrates of the Fbw7 SCF complex 
accumulate when Csn5 is depleted. Cells were induced with doxycycline for eight days followed by SDS-PAGE/western blot 
analysis for the indicated proteins. (B) Activity of the protein kinase cyclin E/Cdk2 is increased when cells are depleted for 
Csn5. Cells were induced with doxycycline for eight days followed by lysis under native conditions. Lysates were immunopre-
cipitated with antibodies toward cyclin E and immuoprecipitates analyzed for kinase activity against histone H1. (C) Cell cycle 
regulation of cyclin E is lost when cells are depleted for Csn5. Cells were induced with doxycycline for eight days followed by 
arrest at the indicated cell cycle stages. Cell lysates were analyzed by SDS-PAGE/western blot with the indicated antibodies.BMC Biochemistry 2006, 7:1 http://www.biomedcentral.com/1471-2091/7/1
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decreases in the steady-state protein levels of Skp2, cyclin
F, Fbw7, Fbx4 and Fbx7 (Figure 2A). To test whether this
decrease in protein levels was post-transcriptional, we per-
formed RT-PCR on the corresponding mRNA transcripts.
Despite the significant drop in protein levels, there was lit-
tle change in mRNA levels, suggesting that for 4 of the 5 F-
box proteins examined (Fbx4 being the exception) the
loss of protein was due to reduced translation or increased
degradation (Figure 2B). Interestingly, two F-box proteins,
β-TrCP and Emi1, showed little or no change in protein
level when Csn5 was suppressed (data not shown).
To determine if the decrease in F-box protein levels was
specific and due to loss of JAMM isopeptidase activity, we
ectopically expressed mouse Csn5 in cells depleted of
endogenous Csn5 by shRNA. Transfection of wild-type
mouse  CSN5  cDNA, which differs by two nucleotides
from human CSN5 in the region that is targeted by the
silencing shRNA, restored wild-type levels of both Skp2
and cyclin F (Figure 3B). In contrast, expression of two dif-
ferent JAMM point mutants of mouse Csn5 failed to
restore Skp2 and cyclin F protein levels, despite normal
levels of expression of the mutant proteins (Figure 3B).
The protein levels of Fbx4 could not be rescued by overex-
pression of wild-type mouse CSN5, suggesting that loss of
Fbx4 arose from a promiscuous effect of the CSN5-
directed siRNA and was not due to Csn5 knockdown
(data not shown), Therefore, the reduction in Skp2 and
cyclin F levels in Csn5-depleted cells is caused by the loss
of CSN isopeptidase activity.
Loss of F-box proteins is dependent on the ubiquitin-
proteasome system
We next examined whether the 26S proteasome was
involved in the reduction of F-box protein levels. Treat-
ment of Csn5-depleted cells with the proteasome inhibi-
tor MG132 largely restored normal levels of Fbx7, cyclin
F, and Fbw7, whereas Skp2 levels were only partially res-
cued (Figure 3A). By contrast, the loss of Fbx4 was not
reversed by proteasome inhibition, which is consistent
with our prior observation that Csn5 shRNA non-specifi-
cally diminished the levels of Fbx4 transcripts. Similar
results were obtained for all proteins when we used the
proteasome inhibitor LLnL. Therefore, the loss of F-box
proteins in Csn5-depleted cells appears to depend largely
upon the 26S proteasome.
The role of the proteasome in mediating the loss of F-box
proteins in Csn5-depleted cells suggested that Csn5 might
normally protect F-box proteins within SCF complexes
from being 'autoubiquitinated' by the associated E2
enzyme and then degraded. To address this possibility we
sought to examine the levels of a representative F-box pro-
tein in cells in which Csn5 was depleted and SCF activity
was simultaneously inhibited. A C-terminal truncation
mutant of Cul1 [Cul1 (1–428)] possesses dominant-neg-
ative activity [27]. To determine if the loss of cyclin F in
Csn5-depleted cells was SCF dependent, we transiently
expressed either wild-type or Cul1 (1–428) in doxycy-
cline-induced cells. Whereas expression of full length
Cul1 did not alter cyclin F accumulation, expression of
Cul1 (1–428) restored cyclin F to levels comparable to
those seen in untreated cells (Figure 3C). These data indi-
cate that loss of cyclin F was dependent upon an intact
SCF complex.
Loss of Fbw7 results in a marked increase in substrate levels
Given the reduction in Fbw7 levels in Csn5-depleted cells,
we analyzed two substrates of SCFFbw7 – cyclin E and c-
myc – to see if they were stabilized. Down-regulation of
Csn5 resulted in accumulation of both c-myc and cyclin E
(Figure 4A) as well as cyclin E-associated histone H1
kinase activity (Figure 4B). Moreover, depletion of Csn5
resulted in a loss of cell cycle regulation of cyclin E protein
abundance (Figure 4C), which is consistent with a defect
in cyclin E turnover.
Overexpression of a non-degradable form of cyclin E
results in chromosome instability [28]. To examine chro-
mosome stability in Csn5-depleted cells, we induced cells
for 21 days with doxycycline and examined them for chro-
mosome abnormalities by FISH and karyotyping. Despite
a significant increase in cyclin E, we could not detect any
chromosomal abnormalities (data not shown).
Discussion
CSN downregulates the activity of SCF ubiquitin ligase in
biochemical reconstitution assays [3-6] whereas loss of
CSN components in several different organisms causes a
defect in SCF activity in vivo [4,7,20-25]. To understand
the basis for these paradoxical observations, we investi-
gated the nature of SCF complexes in cells deprived of
CSN activity. Here, we report that suppression of Csn5 in
human cells resulted in a decrease in steady-state F-box
protein levels. This decrease was post-transcriptional,
stemmed from loss of the metallopeptidase activity of
Csn5, and was largely proteasome-dependent. For cyclin
F, the reduction in levels was blocked by a dominant-neg-
ative mutant of Cul1. As a consequence of the decline in
F-box protein levels, ligands that are targeted for degrada-
tion by these F-box proteins are expected to accumulate.
Indeed, both cyclin E and c-myc, substrates of SCFFbw7,
accumulated in Csn5-depleted cells. Although our study
focused on F-box substrate receptor subunits of SCF, we
anticipate that depletion of Csn5 will have similar conse-
quences for VHL box, BTB domain, and SOCS box pro-
teins that deliver substrates to Cul2, Cul3, and Cul5,
respectively.BMC Biochemistry 2006, 7:1 http://www.biomedcentral.com/1471-2091/7/1
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Loss of Csn5 causes both loss of deneddylation activity
and loss of CRL-associated deubiquitination activity
mediated by the deubiquitinating enzyme Ubp12 [6].
Ubiquitination and turnover of CRL substrate receptor
proteins is suppressed by Ubp12 [13], and thus it is possi-
ble that the loss of F-box proteins that we observed in
Csn5-depleted cells was due to loss of either deneddyla-
tion by Csn5 and/or F-box protein deubiquitination by
Ubp12. However, expression of Csn5 carrying point
mutations in the JAMM motif did not restore cyclin F or
Skp2 protein levels in cells depleted of endogenous Csn5
(Figure 3B), even though human CSN complexes bearing
a mutated JAMM domain possess associated deubiquiti-
nating activity equivalent to that of wild type CSN [4].
Thus, we propose that loss of CSN-dependent deneddyla-
tion is sufficient to bring about a reduction of steady-state
F-box protein levels in human cells.
The exact mechanism by which the substrate adaptors are
turned over in Csn5-depleted cells is unknown. However,
the stimulatory effect of neddylation on SCF activity in
vitro [3-6] and the restoration of cyclin F levels by domi-
nant-negative Cul1 in Csn5-depleted cells suggests an
autocatalytic mechanism wherein an F-box protein is
ubiquitinated by the neddylated Cul1-Hrt1 catalytic mod-
ule present in the same SCF complex. We propose that
once an SCF ubiquitin ligase exhausts its pool of available
substrate, deneddylation of the Cul1 subunit by CSN
brings about disassembly of the complex, with the end
result being that the Skp1-F-box heterodimer is released
and Cul1-Hrt1 are sequestered into an inactive assem-
blage with CAND1. In Csn5-depleted cells, the inactiva-
tion process is not initiated and therefore the F-box
protein remains constitutively associated with a highly
active, neddylated cullin-RING catalytic core, resulting in
a high rate of F-box protein ubiquitination and degrada-
tion.
Interestingly, whereas most F-box proteins that we exam-
ined (e.g. cyclin F) exhibited a significant decline in levels
upon depletion of Csn5, others (β-TrCP, Emi1) were not
affected (G.A.C., unpublished data). We do not under-
stand the basis for this difference, but it is unlikely to
reflect whether a given F-box protein is turned over in nor-
mal cells, because β-TrCP levels were not reduced in Csn5-
depleted cells even though transfected β-TrCP is turned
over with a reasonably brisk half-life of ~120 minutes
[29]. Clearly, more work is needed to determine why accu-
mulation of only some F-box proteins depends upon
CSN.
Given the substantial reduction in the steady-state levels
of multiple F-box proteins upon depletion of Csn5, it is
surprising that depleted cells continued to proliferate with
normal cell cycle kinetics and did not exhibit a dramatic
phenotype. For example, overexpression of cyclin E [28]
or deletion of Fbw7 [30] causes chromosomal instability,
but we were unable to detect any measurable defect in
chromosome status in Csn5-depleted cells (data not
shown). Given that depletion of Csn5 can affect so many
different F-box proteins and presumably SOCS/BC box
and BTB domain proteins as well, it is possible that
opposing pathways were perturbed in such a way as to
prevent the onset of chromosome instability. A similarly
mild growth effect of depleting Csn5 was seen in a previ-
ous study of the normal diploid human fiboroblast BJ1
cell line [4]. As we have noted previously, the function of
Csn5 may be more critical in a multicellular context, or in
the face of differentiation signals that evoke a major
change in the repertoire of cellular proteins [15].
While this manuscript was in preparation, it was reported
that loss of function mutations in CSN components in S.
pombe and Neurospora renders the substrate-recruiting sub-
units of both Cul1 and Cul3-based CRL complexes unsta-
ble, resulting in accumulation of their respective targets
[13,31]. In addition, deneddylation of cullins mediated
by CSN is required for the maintenance of cullin protein
levels in Drosophila and for Cul1 stability in Neurospora
[31,32]. In our original studies in S. pombe [3], we
observed normal levels of Cul1 in a csn1∆ mutant, and
this result has been confirmed and extended to other cul-
lins in S. pombe [6,13] as well as Arabidopsis thaliana [33].
The results reported here indicate that accumulation of
human cullins does not depend on CSN-dependent
deneddylation. It is unclear why human, fission yeast, and
Arabidopsis cullins behave differently from those of Dro-
sophila and Neurospora.
Conclusion
We have shown that CSN can stabilize F-box proteins,
thus acting positively on SCF. CSN has been shown to par-
ticipate in several different processes, including develop-
ment, transcription, and cell cycle progression [reviewed
in [15]]. We propose that loss of deneddylation and a con-
sequent decline in F-box protein abundance underlies
these phenotypes.
Methods
Cell culture, cell lines and plasmids
HEK293 cell lines were obtained from ATCC. Cell Lines
were grown in Minimum Essential Media (MEM) supple-
mented with 10% FBS and grown at 37C with 5% CO2.
For G1 cell cycle arrest, cells were grown in MEM media
without Serum for 24 hours. For G2 cell cycle arrest, cells
were treated with 330 nM of Nocodazole (Sigma) for 24
hours. All transfections were preformed using the calcium
phosphate method. Briefly, cells were grown to a density
of 1.2–2.0 × 106 cells per 6 cm plate. 5 ug of DNA was
mixed to a volume of 450 uL and 50 uL of 2.5 M CaCl2BMC Biochemistry 2006, 7:1 http://www.biomedcentral.com/1471-2091/7/1
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was added. 500 uL of BBS (0.05 M BES, 0.28 M NaCl,
0.0015 M Na2 HPO4, pH 7.0) was added and solution vor-
texed to mix. Cells were re-fed with fresh MEM supple-
mented with 2.5 uL/mL 25-hydroxycholesterol (Sigma).
Precipitate was applied to cells and incubated for 4 hours
prior to removal with PBS. Cells were re-fed with fresh
MEM and incubated 24–48 hours. All plasmids used in
this study are listed in Table 1.
Construction of stable cell lines
HEK293 cells were transfected with pGC95 (control
scrambled shRNA, 5'-CGTGCAAGGTCAGTACATGT-
TCAAGAGACATGTACTGACCTTGCACG) or pGC93 (5'-
TGCTCAGGCTGCTGCATATTTCAAGAGAATATGCAG-
CAGCCTGAGCA). 24 hours after transfection, cells were
re-fed with MEM supplemented with 5 ug/mL puromycin
and selected for 48 hours. Post-selection, cells were grown
for 7–10 days and single colonies were selected. Two rep-
resentative clonal expansions (1A and 2F) of pGC93 are
shown.
mRNA analysis
RNA was purified from cells using Qiagen RNeasy kits.
After purification, RNA was normalized by concentration
used as a template for stratascript reverse transcriptase fol-
lowing manufacturers protocols (stratagene). Reverse
transcribed RNA was then used for PCR towards Csn5, β-
Actin, cyclin F, Fbx4, Fbx7, Fbw7, and Skp2.
Protein analysis
Native lysates were made by resuspending cell pellets in
an equal volume of buffer A (25 mM TRIS (7.5), 150 mM
NaCl, 0.3% Triton X-100, 1 mM EDTA and 1 mM DTT
supplemented with 1 mM PMSF, 0.25 ug/mL pepstatin,
and 5 ug/mL each of leupeptin, aprotinin, and chymot-
rypsin). Lysates were cleared by centrifugation and nor-
malized using the Biorad Protein Assay (Biorad).
Denatured lysates were made by resuspending cell pellets
in an equal volume of boiling SDS buffer (2% SDS, 50
mM TRIS (7.5) and 5 mM DTT) and boiled for 5 minutes.
Lysates were sonicated and cleared by centrifugation.
Antibodies
The following antibodies were used in this study: Fbw7
(Orbigen PAB-10563), cyclin F (Santa Cruz Biotechnol-
ogy sc-952), cyclin E (Santa Cruz Biotechnology sc-198),
Csn5 (Santa Cruz Biotechnology sc-9074), β-tubulin
(Santa Cruz Biotechnology sc-9104) Fbx7 (Zymed 51–
8000) and c-myc (Santa Cruz Biotechnology sc-42). Skp2
was generously provided by W. Krek and Fbx4 was gener-
ously provided by W. Boelens.
Histone H1 kinase assay
Native lysates were immunoprecipitated for 1 hour with
antibodies toward cyclin E. Immunoprecipitates were
washed 3 times in native lysis buffer (buffer A). Beads
were resuspended in 10 uL of reaction mix (for 100 uL: 3
uL 5 mg/mL histone H1, 1.5 uL 4.5 mM ATP, 1.5 uL γ-32P
ATP, 94 uL of kinase assay buffer (10 mM TRIS (7.5), 10
mM MgCl2, 50 mM NaCl, 2 mM EDTA, 1 mM DTT and
0.02% Triton X-100)). Reactions were incubated for 20




SCF: SKP1/Cullin/F-box protein complex
JAMM: Jab1/MPN domain metalloenzyme motif
BTB: "bric-a-brac/tramtrack/broad" protein complex
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Table 1: Plasmids used in this study
Plasmid Reference Description
pGC95 This study Tetracycline inducible scrambled siRNA
pGC93 This study Tetracycline inducible siRNA to human Csn5.
RJD 1419 This study CMV Flag-Csn5
RJD 1500 This study CMV Flag-Csn5 (ASA)
RJD 1501 This study CMV Flag-Csn5 (D151N)
RJD 942 [34] HA-Cul1
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